drugset / Trial / NCT00361153

Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

NCT00361153

Phase 2 Completed 35 enrolled Daiichi Sankyo
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is designed to test whether WelChol (colesevelam HC1) improves blood sugar control in patients with type 2 diabetes by making their own insulin work more efficiently.

Timeline

Start
2006-05
Primary completion
2006-10
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colesevelam Other / unclassified 3.75 g